H2BioCat: asymmetric reductions
Product Description
HydRegen Limited
-
GB
-
2024On CPHI since
-
1 - 24Employees
Company types
Primary activities
Categories
Specifications
HydRegen Limited
-
GB
-
2024On CPHI since
-
1 - 24Employees
Company types
Primary activities
More Products from HydRegen Limited (2)
-
Product Bio2Amine: nitro-to-amine reduction
Bio2Amine™ is an enzyme on carbon hydrogenation catalyst with similar handling to common precious-metal on carbon catalysts. Using HydRegen technology to provide industrial reactions under mild conditions we are:
• Lowering energy requirements and, improving specificity • Bio2Amine™ is recommende... -
Product Bio2Amine for Mesalazine (mesalamine)
Mesalazine (mesalamine, 5-aminosalicylic acid)
Pharmaceutical indicated for ulcerative colitis, Crohn’s disease, inflammatory bowel disease.
For the reduction of 5-nitrosalicylic acid (5-NSA), Bio2Amine™ facilitates highly selective hydrogenation to 5-aminosalicylic wit...
HydRegen Limited resources (1)
-
Video HydRegen introduction
Biotech for cleaner, cheaper and safer chemical manufacturing.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance